News Story: Full Text
Sponsored By
Orbus Therapeutics Inc Clinical Trial for Recurrent Anaplastic Astrocytomas
Please Click On The Above Banner For More Details
Braintumor Website


Medicare approves payment for Gliadel Wafer!

Posted on: 08/02/2007

Medicare approves payment for Gliadel Wafer!


The Center for Medicare and Medicaid (CMS) announced today that they  agreed to assign all Gliadel® cases to MS-DRG 23.  The title for MS-DRG 023 is changed to “Craniotomy with Major Device Implant or Acute Complex Central Nervous System Principal Diagnosis with MCC or Chemo Agent"

This is exactlly what we asked for in our recent letter writing campaign. I do not know if the campaign helped or not, but CMS did mention, in their announcement, that there were "Many commenters encouraged CMS to reassign these cases to DRG 23"!

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557